Ukraine is a drug tracked in our intelligence system with 5 linked articles.
A market-map piece listing 72 European defence-tech startups; informative for directional insight but offers limited financials or regulatory specifics.
The piece argues that threats to annihilate Iran’s civilian power infrastructure would risk war crimes unless targeting adheres to strict proportionality and distinction, and it outlines the law-of-war framework (including collateral-damage methods and no-strike protections) governing such decisions.
Ukraine’s defence-tech sector surged from around 50 private firms in 2021 to about 800 by 2025, with this piece listing 14 defence-tech companies to watch and including investor perspectives.
A Ukrainian domestically produced strike UGV (TW 12.7) held a frontline position for six weeks during a 45-day mission, underscoring growing robotic warfare maturity and the role of automation in infantry support.
Five European unicorns were minted in January, spanning from Belgium to Ukraine.
Preply hits unicorn status with a $1.2B valuation after a $150M round, highlighting resilience of a Ukrainian-founded edtech player.
Subscribe for real-time drug updates and unlimited access to our intelligence platform.